Nanospectra Biosciences
- L. Blair Shamel
L. Blair Shamel has Thirty years’ sales, marketing and commercialization experience in the business of prostate cancer. Launched first commercial assay for PSA. Experience includes Hybritech, Ablation Technologies, DiagnoCure, Metabolon and SNP Bio.